Aescin (escin) derived from the seeds of horse chestnut (Aesculus hippocastanum L.) is a natural mixture of triterpene saponins exhibiting a wide variety of pharmacological properties, including antiinflammatory, analgesic, and antipyretic activities. However, data concerning antifungal activities of these compounds are limited. This study aims to evaluate the in vitro antifungal susceptibility of Candida glabrata clinical isolates to α-aescin sodium, β-aescin crystalline and β-aescin sodium using the disk diffusion (DD) and broth microdilution (BMD) methods. Moreover, the influence of subinhibitory concentration (0.5×MIC) of β-aescins on the nystatin MIC was also studied. In general, the results obtained by the DD assay correlated well with those obtained by the BMD method. Both β-aescins effectively inhibited the growth of all 24 strains tested. The minimum inhibitory concentration (MIC) values ranging from 8 to 32 μg/ml for β-aescin crystalline, whereas those of β-aescin sodium were slightly lower and ranged from 4 to 16 μg/ml. In contrast, α-aescin sodium was found to be completely ineffective against the strains studied. MIC values of nystatin were reduced 2-16-fold and 2-4-fold in the presence of subinhibitory concentration of β-aescin crystalline and β-aescin sodium, respectively. Results of the present study may suggest the additive interaction between β-aescin and nystatin.
Introduction
Candida albicans still remains the leading human fungal pathogen. In recent years, however, a progressive increase in infections caused by non-albicans Candida species, such as Candida glabrata, has been reported worldwide [1] [2] [3] [4] . Historically, C. glabrata has been recognized as a commensal yeast belonging to the normal microbiota of the oral cavity, gastrointestinal and genital tracts, rarely associated with serious infections in humans. However, under certain circumstances, C. glabrata, like other yeasts, is capable of causing a variety of diseases from mucocutaneous infections to severe and life-threatening invasive candidemia, especially in critically ill and immunocompromised patients [5, 6] . The epidemiology of fungal infections caused by this yeast species varies depending on the geographical region. It has been demonstrated that C. glabrata was one of the most frequent causes of candidaemia in patients with hematologic malignancies in Texas during the period 1993-2003 [1] . The results of retrospective study conducted by Asmundsdottir et al. [4] revealed, that C. glabrata was the second most prevalent yeast species responsible for systemic infections in Iceland during a 12-year period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) . In Polish hospitals in years 2006-2007 the percentage of candidemia episodes caused by this yeast species was shown to be 14.1% [7] . Moreover, C. glabrata clinical isolates often display intrinsic as well as acquired antifungal resistance that reduce significantly therapeutic options and may lead to treatment failure. According to Silva et al., [8] infections caused by C. glabrata are often associated with higher morbidity and mortality rates than those caused by C. albicans.
To overcome these problems, new antifungal agents targeting drug-resistant yeasts are urgently needed. During the past decades, many efforts have been devoted to isolating compounds from natural sources, which could potentiate the effect of conventional antifungal therapy, either when administered alone or in combination with classical antifungals [9] [10] [11] .
The aim of the present study was to investigate the in vitro antifungal activity of three aescin compounds, including α-aescin sodium (αAE-Na), β-aescin crystalline (βAE-C), and β-aescin sodium (βAE-Na) against clinical isolates of C. glabrata. In addition, the influence of subinhibitory concentration (0.5 × MIC) of β-aescins on the nystatin (NYT) MIC was also investigated.
Material and methods

Strains
A total of 24 C. glabrata clinical isolates were collected during a three-year period (2011-2013) from patients hospitalized in the Medical University Hospital in Wrocław, Poland. These isolates were recovered from various specimen types such as blood, urine, feces, throat swab, sputum, catheter, bronchial aspiration, and vagina and were nonrepetitive. The identity of the strains was confirmed using colony color characteristics of CHROMagar Candida (Oxoid, Basingstoke, Hampshire, UK) and commercially available ID32Ctest strips (bioMérieu Marcy-l'Etoile, France) according the manufacturer's recommendations. Additionally, C. glabrata ATCC 90030 was used as reference strain for quality control and to monitor the reproducibility of in vitro susceptibility testing.
Chemicals α-aescin sodium (αAE-Na) was obtained from Roth (Karlsruhe, Germany). β-aescin crystalline (βAE-C) was kindly supplied by Noblius Ent (Warsaw, Poland), whereas β-aescin sodium (βAE-Na) by Labor (Wroclaw, Poland). NYT (151.26 mg = 10 6 units) was purchased from Cosmetics Pharma (Warsaw, Poland). The chemicals were prepared as a 10 mg/ml stock solutions in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, USA) and then aliquoted and stored at −80 o C until used.
Antifungal susceptibility testing
Antifungal susceptibility to α-aescin sodium (αAE-Na), β-aescin crystalline (βAE-C), β-aescin sodium (βAE-Na) and nystatin (NYT) was performed by the disk diffusion (DD) and broth microdilution (BMD) methods.
Disk diffusion (DD) testing
DD in vitro susceptibility tests were done in accordance with Clinical and Laboratory Standards Institute (CLSI) document M44-A [12] . Mueller Hinton agar (Becton Dickinson, Sparks, USA) supplemented with 2% dextrose and 0.5 mg/l methylene blue was used as the basic media. The yeast inocula were adjusted to the turbidity of a 0.5 McFarland standard (approximately 1-5 × 10 6 CFU/ml) in sterile saline (0.85%) and streaked onto agar plates using sterile cotton swabs. The standard paper disks (6 mm in diameter; Becton Dickinson, Sparks, USA) were taken in a blank petri dish under the laminar hood. Then disks were saturated with 10 μl of different aescin stock solutions (10 mg/ml) to obtain the desired concentration of 100 μg per disk. Dried disks were placed aseptically on the agar surface. NYT (15 μg/disk) and free solvent (sterile saline) were used as positive and negative controls, respectively. C. glabrata ATCC 90030 reference strain was included in each susceptibility test for quality control and assessment of reproducibility. The results were determined based on the inhibition zone diameter after incubating at 35
h. All assays were performed in triplicate, and the results were expressed as means ± standard deviation (SD) of three independent experiments.
Minimum inhibition concentration (MIC) determination
The MIC values of α-and β-aescins for 24 C. glabrata strains tested and C. glabrata ATCC 90030 reference strain were determined by the two-fold broth microdilution (BMD) method according to the guidelines M27-A3, Table 1 . In vitro susceptibilities of Candida glabrata isolates to α-aescin sodium (αAE-Na), β-aescin crystalline (βAE-C), and β-aescin sodium (βAE-Na) determined by disk diffusion (DD) and broth microdilution (BMD) methods. recommended by the Clinical and Laboratory Standards Institute [13] . The MIC of NYT was determined alone or in the presence of a fixed subinhibitory concentration (0.5×MIC) of βAE-C or βAE-Na. The testing was carried out in sterile flat-bottomed 96-well microtiter plates with an inoculum concentration of 0.5 × 10 3 to 2.5 × 
Results
The in vitro antifungal activities of αAE-Na, βAE-C and βAE-Na were determined against 25 C. glabrata strains, including 24 clinical isolates and one C. glabrata ATCC 90030 reference strain. The results of the disk diffusion (DD) and broth microdilution (BMD) methods are shown in Table 1 and Figure 1 . Generally, results obtained by DD assay were consistent with those determined by BMD method; an increase of MIC values was accompanied by a decrease of inhibition zone diameters and vice versa. In our study, αAE-Na did not exhibit any antifungal activity against the yeasts tested. Lack of activity of this compound correlated very well with the absence of inhibition zones in DD method. By contrast, both β-aescins (βAE-C and βAE-Na) effectively inhibited the growth of all C. glabrata strains with a zone diameter ranging from 13.8 to 22.1 mm Figure 1 . Disk diffusion results of α-aescin sodium (αAE-Na), β-aescin crystalline (βAE-C), β-aescin sodium (βAE-Na) and nystatin (NYT) for two selected Candida glabrata isolates.
for βAE-C and from 20.0 to 28. for βAE-C and βAE-Na, respectively. The further studies were designed to evaluate the influence of subinhibitory concentrations (0.5×MIC) of βAE-C or βAE-Na on the nystatin MIC for the each strains tested. As shown in Table 2, the in vitro MIC values of NYT alone varied from 1.0 to 32.0 μg/ml, while those determined in the presence of sub-MIC of β-aescins were slightly lower ranging from 0.125 to 8.0 μg/ml for βAE-C and from 0.25 to 8.0 μg/ml for βAE-Na depending on the strains tested. The results obtained indicate that sub-MIC of βAE-C reduced 2-to 16-fold MICs of NYT. On the other hand, sub-MIC of βAE-Na resulted in 2-to 4-fold reduction of nystatin MICs.
Discussion
The prevalence of infections caused by antibiotic-resistant microorganisms has increased dramatically over the past few decades. The failure of the conventional antimicrobial treatment is now the most important challenge to researchers and pharmaceutical industry. Therefore, there is an urgent need for new drugs and antimicrobial strategies. More and more studies have focused on the possibility of using natural plant-derived substances in antimicrobial therapy. In fact, plant extracts are regarded as the invaluable sources of secondary metabolites endowed with a variety of pharmacological properties [14] [15] [16] . A considerable number of plant originated compounds have already proved their antimicrobial activities when used alone or in combination with traditional antibiotics [10, 17] . Saponins synthesized constitutively by different plants represent one of the most common and widespread phytoanticipins involved in plant defense through their antimicrobial potency [18] [19] [20] . According to the literature, saponins extracted from different plants display important antifungal activity against both yeasts and filamentous fungi [17, [21] [22] [23] [24] [25] . In a study of Zhang et al., [17] saponins extracted from Tribulus terrestris L. were found to be very effective against fluconazole-resistant pathogenic yeasts, including C. glabrata. Similar results were reported by Du et al., [23] who demonstrated antifungal efficacy of triterpenoid saponins with hederagenin or oleanolic acid as aglycones against various yeast species, including C. glabrata as well as dermatophytes such as Microsporum canis and Trichophyton mentagrophytes. The findings reported by Tsuzuki et al. [24] confirmed the antifungal activity of saponins derived from Sapindus saponaria against nonCandida albicans species, especially C. parapsilosis. The studies mentioned above inspired us to investigate the antifungal activities of natural compounds extracted from the seeds of horse chestnut (Aesculus hippocastanum L.) known under the collective name aescin. It is a mixture of triterpenoid saponins consisting of two forms α-and β, which vary mainly by solubility in water, haemolytic index, melting point and specific rotation [26] . The main component of the horse chestnut extract is β-aescin (Fig. 2 ) that was shown to exhibit a broad spectrum of pharmacological properties, including antiinflammatory, analgesic, and antipyretic activities. Extract from seeds and bark of the Aesculus hippocastanum L. (Hippocastanaceae) is today used as herbal medicine in Europe against chronic venous insufficiency (CVI; i.e., varicose veins accompanied with pain, oedema, pruritus, and a sense of heaviness). Table 2 . MIC values of nystatin (NYT) alone or in the presence of subinhibitory concentration (0.5×MIC) of β-aescin crystalline (βAE-C) or β-aescin sodium (βAE-Na) for Candida glabrata isolates.
inhibit the growth of the yeasts tested. Moreover, β-aescin sodium exhibited stronger anticandidal activity compared with β-aescin crystalline. Previous studies have shown that polyene antibiotics, such as nystatin and aescin share a common mode of action. Both compounds exert their effects by interacting with sterol molecules within the fungal cell membrane, leading to the formation of transmembrane pores [31] . This process disturbs the cellular semi-permeability and leads to the death of the fungal cell. Nystatin is able to form small barrel-shaped pores with a radius of approximately 0.42 nm in fungal membrane whose permeability is limited to monovalent cations and small molecules [32] . By contrast, aescin pores, with a radius of 2.56 nm, are permeable to larger molecules, such as nucleotides and drugs [31] . In the present study, β-aescin crystalline as well as β-aescin sodium at their subinhibitory concentrations decreased the nystatin MIC values for all C. glabrata isolates tested. It is interesting to note that nystatin MIC reduction was greater for β-aescin crystalline although this compound displayed lower antifungal potency against the strains studied relative to β-aescin sodium. Our findings revealed that MICs of nystatin-β-aescin combination were lower compared with those obtained for the individual compounds. These results may confirm a synergistic or additive effect of nystatin and β-aescin against the C. glabrata strains tested, however, further studies are needed to explain the exact interaction between these agents.
In conclusion, the findings of the present study authenticated the effective in vitro anticandidal activity of β-aescin. In addition, nystatin-β-aescin combination may be a useful strategy to potentiate the effect of conventional antifungal therapy.
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